Search research articles
Contact Us
Filters
Showing results (21-30 of 481) with videos related to
Page
of 49
Sort By:
European Journal of Preventive Cardiology
|
November 28, 2013
Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia
Zanfina Ademi, Kumar Pasupathi, Danny Liew
The New Zealand Medical Journal
|
May 8, 2020
An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme-subanalyses for Māori (ANZACS-QI 42)
Peter Lee, Ella Zomer, Danny Liew
Neurology
|
February 19, 2016
Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment
Zhibin Chen, Danny Liew, Patrick Kwan
Current Opinion in Investigational Drugs (London, England : 2000)
|
May 15, 2003
Eplerenone. Pharmacia
Danny Liew, Jennifer Martin, Henry Krum
British Journal of Clinical Pharmacology
|
May 3, 2020
Cost-effectiveness and financial risks associated with immune checkpoint inhibitor therapy
Hansoo Kim, Danny Liew, Stephen Goodall
Plos One
|
May 9, 2014
Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions
Zhibin Chen, Danny Liew, Patrick Kwan
Applied Health Economics and Health Policy
|
October 5, 2016
Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective
Zanfina Ademi, Kumar Pasupathi, Danny Liew
International Journal of Health Policy and Management
|
July 3, 2020
The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"
Hansoo Kim, Stephen Goodall, Danny Liew
The Medical Journal of Australia
|
November 12, 2003
Emergency department length of stay independently predicts excess inpatient length of stay
Don Liew, Danny Liew, Marcus P Kennedy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease
Jedidiah I Morton, Danny Liew, Zanfina Ademi
Page
of 49
Search research articles
Search
Showing results (21-30 of 481) with videos related to
Sort By:
Page
of 49
European Journal of Preventive Cardiology
|
November 28, 2013
Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia
Zanfina Ademi, Kumar Pasupathi, Danny Liew
The New Zealand Medical Journal
|
May 8, 2020
An economic evaluation of the All New Zealand Acute Coronary Syndrome Quality Improvement Registry programme-subanalyses for Māori (ANZACS-QI 42)
Peter Lee, Ella Zomer, Danny Liew
Neurology
|
February 19, 2016
Real-world cost-effectiveness of pharmacogenetic screening for epilepsy treatment
Zhibin Chen, Danny Liew, Patrick Kwan
Current Opinion in Investigational Drugs (London, England : 2000)
|
May 15, 2003
Eplerenone. Pharmacia
Danny Liew, Jennifer Martin, Henry Krum
British Journal of Clinical Pharmacology
|
May 3, 2020
Cost-effectiveness and financial risks associated with immune checkpoint inhibitor therapy
Hansoo Kim, Danny Liew, Stephen Goodall
Plos One
|
May 9, 2014
Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions
Zhibin Chen, Danny Liew, Patrick Kwan
Applied Health Economics and Health Policy
|
October 5, 2016
Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective
Zanfina Ademi, Kumar Pasupathi, Danny Liew
International Journal of Health Policy and Management
|
July 3, 2020
The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"
Hansoo Kim, Stephen Goodall, Danny Liew
The Medical Journal of Australia
|
November 12, 2003
Emergency department length of stay independently predicts excess inpatient length of stay
Don Liew, Danny Liew, Marcus P Kennedy
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 2, 2024
A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease
Jedidiah I Morton, Danny Liew, Zanfina Ademi
Page
of 49